Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs : The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy Study
- Author
- GENOVESE, Mark C1 ; MCKAY, James D2 ; NASONOV, Evgeny L3 ; MYSLER, Eduardo F4 ; DA SILVA, Nilzio A5 ; ALECOCK, Emma6 ; WOODWORTH, Thasia6 ; GOMEZ-REINO, Juan J7
[1] Stanford University Medical Center, Palo Alto, California, United States
[2] Oklahoma State University, Tulsa, United States
[3] Institute of Rheumatology, Moscow, Russian Federation
[4] Organization for Medical Investigations, Buenos Aires, Argentina
[5] Medical School of the Federal University of Goiás, Goiania, Goiás, Brazil
[6] Roche Products Ltd, Welwyn, United Kingdom
[7] Rheumatology University Hospital, and University of Santiago de Compostela, Santiago de Compostela, Spain - Source
Arthritis and rheumatism. 2008, Vol 58, Num 10, pp 2968-2980, 13 p ; ref : 40 ref
- CODEN
- ARHEAW
- ISSN
- 0004-3591
- Scientific domain
- Rheumatology
- Publisher
- Wiley, Hoboken , NJ
- Publication country
- United States
- Document type
- Article
- Language
- Russian
- Keyword (fr)
- Antirhumatismal Association médicamenteuse Chronique Immunomodulateur Interleukine 6 Polyarthrite rhumatoïde Rhumatologie Tocilizumab Traitement Indice d'activité Immunopathologie Maladie autoimmune Pathologie du système ostéoarticulaire Rhumatisme inflammatoire
- Keyword (en)
- Antirheumatic agent Drug combination Chronic Immunomodulator Interleukin 6 Rheumatoid arthritis Rheumatology Tocilizumab Treatment Activity index Immunopathology Autoimmune disease Diseases of the osteoarticular system Inflammatory joint disease
- Keyword (es)
- Antireumático Asociación medicamentosa Crónico Inmunomodulador Interleuquina 6 Poliartritis reumatoidea Reumatología Tocilizumab Tratamiento Inmunopatología Enfermedad autoinmune Sistema osteoarticular patología Reumatismo inflamatorio
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02L Bones, joints and connective tissue. Antiinflammatory agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02Q Immunomodulators
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B15 Diseases of the osteoarticular system / 002B15D Inflammatory joint diseases
- Discipline
- Osteoarticular pathology Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 20759588
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1002/art.23940 
https://dx.doi.org/10.1002/art.23940
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/art.23940\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:266:\"Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs : The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy Study\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Arthritis and rheumatism\";s:9:\"\u0000*\u0000stitle\";s:15:\"Arthritis rheum\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"58\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2968\";s:8:\"\u0000*\u0000epage\";s:4:\"2980\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0004-3591\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"GENOVESE\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Mark C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:14:\"MCKAY, James D\";i:1;s:17:\"NASONOV, Evgeny L\";i:2;s:17:\"MYSLER, Eduardo F\";i:3;s:18:\"DA SILVA, Nilzio A\";i:4;s:13:\"ALECOCK, Emma\";i:5;s:17:\"WOODWORTH, Thasia\";i:6;s:19:\"GOMEZ-REINO, Juan J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ARHEAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:266:\"Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs : The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy Study\";s:8:\"\u0000*\u0000place\";s:12:\"Hoboken , NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/art.23940\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:266:\"Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs : The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy Study\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Arthritis and rheumatism\";s:9:\"\u0000*\u0000stitle\";s:15:\"Arthritis rheum\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"58\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2968\";s:8:\"\u0000*\u0000epage\";s:4:\"2980\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0004-3591\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"GENOVESE\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Mark C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:14:\"MCKAY, James D\";i:1;s:17:\"NASONOV, Evgeny L\";i:2;s:17:\"MYSLER, Eduardo F\";i:3;s:18:\"DA SILVA, Nilzio A\";i:4;s:13:\"ALECOCK, Emma\";i:5;s:17:\"WOODWORTH, Thasia\";i:6;s:19:\"GOMEZ-REINO, Juan J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ARHEAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:266:\"Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs : The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy Study\";s:8:\"\u0000*\u0000place\";s:12:\"Hoboken , NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/art.23940\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/art.23940\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:266:\"Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs : The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy Study\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Arthritis and rheumatism\";s:9:\"\u0000*\u0000stitle\";s:15:\"Arthritis rheum\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"58\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2968\";s:8:\"\u0000*\u0000epage\";s:4:\"2980\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0004-3591\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"GENOVESE\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Mark C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:14:\"MCKAY, James D\";i:1;s:17:\"NASONOV, Evgeny L\";i:2;s:17:\"MYSLER, Eduardo F\";i:3;s:18:\"DA SILVA, Nilzio A\";i:4;s:13:\"ALECOCK, Emma\";i:5;s:17:\"WOODWORTH, Thasia\";i:6;s:19:\"GOMEZ-REINO, Juan J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ARHEAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:266:\"Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs : The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy Study\";s:8:\"\u0000*\u0000place\";s:12:\"Hoboken , NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/art.23940\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:266:\"Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs : The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy Study\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Arthritis and rheumatism\";s:9:\"\u0000*\u0000stitle\";s:15:\"Arthritis rheum\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"58\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2968\";s:8:\"\u0000*\u0000epage\";s:4:\"2980\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0004-3591\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"GENOVESE\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Mark C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:14:\"MCKAY, James D\";i:1;s:17:\"NASONOV, Evgeny L\";i:2;s:17:\"MYSLER, Eduardo F\";i:3;s:18:\"DA SILVA, Nilzio A\";i:4;s:13:\"ALECOCK, Emma\";i:5;s:17:\"WOODWORTH, Thasia\";i:6;s:19:\"GOMEZ-REINO, Juan J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ARHEAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:266:\"Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs : The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy Study\";s:8:\"\u0000*\u0000place\";s:12:\"Hoboken , NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/art.23940\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:266:\"Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs : The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy Study\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Arthritis and rheumatism\";s:9:\"\u0000*\u0000stitle\";s:15:\"Arthritis rheum\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"58\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:4:\"2968\";s:8:\"\u0000*\u0000epage\";s:4:\"2980\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0004-3591\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"GENOVESE\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Mark C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:14:\"MCKAY, James D\";i:1;s:17:\"NASONOV, Evgeny L\";i:2;s:17:\"MYSLER, Eduardo F\";i:3;s:18:\"DA SILVA, Nilzio A\";i:4;s:13:\"ALECOCK, Emma\";i:5;s:17:\"WOODWORTH, Thasia\";i:6;s:19:\"GOMEZ-REINO, Juan J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ARHEAW\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:266:\"Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs : The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy Study\";s:8:\"\u0000*\u0000place\";s:12:\"Hoboken , NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"13\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
